Male smokers at increased risk for osteoporosis, fractures
the ONA take:
According to a new study published online in the journal Annals of the American Thoracic Society, researchers have found that among middle-aged to elderly tobacco smokers, men were more likely than women to have osteoporosis and vertebral fractures.
For the large study, researchers from National Jewish Health and other institutions analyzed data from 3,321 current and ex-smokers aged 45 to 80 years old. Patients were eligible if they had a minimum 10 pack-year smoking history.
Results showed that 11% of participants had normal bone density, 31% had intermediate bone density, and 58% had low bone density. In addition, 37% had one or more vertebral fractures.
Researchers found that of those with low bone density and vertebral fractures, 55% and 60%, respectively, were men. Results also showed that 84% of participants of both genders with severe chronic obstructive pulmonary disease (COPD) had low-bone density.
Each additional pack-year of tobacco smoking was associated with a 0.4% increased risk of low bone density. The findings suggest that past and current smokers of both genders should be screened for osteoporosis.
Among middle-aged to elderly tobacco smokers, men were more likely than women to have osteoporosis and vertebral fractures.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|